Jim Cramer Blog

Friday's show began with Cramer analysing two new stocks Cramer wants you to buy after the big sell off in the market on Thursday. Cramer said he likes to buy supermarket and drugstore stocks after down days because investors consider them to be safe. His picks were Avon (AVP) and Clorox (CLX). Cramer thinks that they both are doing well internationally, that they have good growth prospects, and that the CEOs of both companies have turned things around.
Tekelec (TKLC): Cramer talked about his weekly speculative pick. They make telecommunications equipment that is focused on next generation networks, giving it strong growth prospects. Cramer also likes that they just completed a stock buyback, meaning they have more cash than some of his speculative plays. Cramer thinks that the stock could go to $16, and that it might be a buyout target for a larger telecommunications company.
After the lightning round, Cramer discussed his Game Plan for next week. He thinks that Citigroup (C) CEO Chuck Prince will either leave the company this weekend, or not at all. If he is still around after Monday, Cramer wants you to move on.
Cramer then talked to Diana Shipping (DSX) CEO Simeon Palios about dry bulk shipping rates, and he left Cramer less bullish about the dry bulk shippers than he had been.
Cramer brought up his earnings plays for this week. Cisco (CSCO) reports on Wednesday, and Cramer thinks you should buy the stock before then. Hologic (HOLX) reports on Tuesday, and Cramer thinks you should also buy some of their stock before they report. He also said that Foster Wheeler (FWLT) and Allergan (AGN) have gone down in the past after earnings, which he thinks is a chance to get these stocks on sale. Cramer also said that he wants you to sell CBS (CBS) and buy ConEd (ED) because it has higher growth and a larger dividend.
Cramer has the CEO of GFI Group (GFIG) on the phone, and they talked about the company's position in the brokerage market, and Cramer said that he is bullish on the stock.

Labels: AVP, CBS, CLX, CNBC, CSCO, DSX, HOLX, Jim Cramer, Mad Money, TKLC

Buy CIT (CIT), Jim Cramer said Monday on CNBC's "Stop Trading!" segment.
Cramer said last week's bad quarter was "scary" as it showed the lender briefly became "a cesspool of bad mortgages." But Cramer added that the New York financial firm is "a really smart company" that's mostly focused on commercial lending, an area Cramer believes "is not causing the problems" in the financial sector. He said he'd buy the stock, which hasn't recovered off last week's hammering.
Cramer said he likes Colgate (CL), Clorox (CLX) and Procter & Gamble (PG) amid signs of a slowdown in worldwide growth.

Labels: CIT, CL, CLX, Jim Cramer, Jim Cramer's Stop Trading, PG

Caterpillar (NYSE: CAT - News) and Google (NasdaqGS: GOOG - News): Cramer would hold on to CAT and GOOG in spite of their disappointing quarters, and comments CAT's decline is just a "pit stop" on the way to $120. Housing is to blame for Caterpillar's setback, while Cramer says Google is a "show me" stock and needs to redeem itself. However, he has confidence in GOOG's revenue growth.
Clorox (NYSE: CLX - News): Cramer speculated on the reasons for CLX's huge $65 call buy, commenting he thought of it as a break-up story rather than a take out story. He would not bet on the possibility that someone has inside information on a take out.

Published by SeekingAlpha

Labels: CAT, CLX, GOOG, Jim Cramer, Stop Trading

Here are 7 trading ideas for today. These lists come directly from the TradingMarkets Stock Indicators page and are based upon our latest quantitative research.
Bullish
5+ Consecutive Down Days: These are stocks that have closed down for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that close down for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.

Sotheby's (NYSE:BID) & Jinpan International (NYSE:JST). BID's PowerRating is 8, and JST's PowerRating is 8.
5+ Consecutive Lower Lows: These are stocks that have made a lower low for five or more consecutive days and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving average that make lower lows for five or more days have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Clorox (NYSE:CLX). CLX's PowerRating is 6.
2-Period RSI Below 2: These are stocks that have a 2-period RSI reading below 2 and are trading above their 200-day moving average. Our research shows that stocks trading above their 200-day moving with a 2-period RSI reading below 2 have shown positive returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
THQ Incorporated (NasdaqGS:THQI) & Zoran (NasdaqGS:ZRAN). THQI's PowerRating is 7, and ZRAN's PowerRating is 7.
Bearish
5+ Consecutive Up Days: These are stocks that have closed up for five or more consecutive days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that close up for five or more days have shown negative returns, on average, 1-week later. Historically, these stocks have provided traders with a significant edge. Historically, these stocks have provided traders with a significant edge.
Advanced Micro Devices (NYSE:AMD). AMD's PowerRating is 3.
5+ Consecutive Higher Highs: These are stocks that have made a higher high for five or more consecutive days and are trading below their 200-day moving average. Our research shows that stocks trading below their 200-day moving average that make higher highs for five or more days have shown negative returns, on average, 1-day, 2-days and 1-week later. Historically, these stocks have provided traders with a significant edge.
Cutera (NasdaqGS:CUTR). CUTR's PowerRating is 4.
PowerRatings are courtesy of PowerRatings.net

Labels: AMD, bid, CLX, CUTR, Hot Stocks, JST, THQI, ZRAN

Cramer’s Top 10 Stock Picks:

1. Halliburton (HAL)
   
2. Caterpillar (CAT)
   
3. Transocean Drilling (RIG)
   
4. Clorox (CLX)
   
5. Altria (MO)
   
6. Hewlett Packard (HPQ)
   
7. Goldman Sachs (GS)
   
8. Sears Holdings (SHLD)
   
9. Fannie Mae (FNM)
   
10. Level 3 Communications (LVLT)

Published by NBC10.com

Labels: CAT, CLX, FNM, GS, HAL, Hot Stocks, HPQ, Jim Cramer, LVLT, MO, RIG, SHLD

Verizon (NYSE: VZ - News), Vonage (NYSE: VG - News): Cramer wanted to talk about "what a bunch of hucksters" the executives at Vonage are concerning the injunction in a patent case with Verizon which brought the stock down 23%. "Everyone thought that VG should be sitting down with Verizon and talking," commented Cramer who thought it was an outrage the VG did just the opposite; "Swap out of VG into anything!"
Clorox (NYSE: CLX - News), ConAgra Foods (NYSE: CAG - News), Union Pacific (NYSE: UNP - News), Norfolk Southern (NYSE: NSC - News), CSX Corp (NYSE: CSX - News): Noting that CLX and CAG have new management, Cramer added that they could be broken up as well as rail companies such as UNP "the largest land owner in America," NSC and CSX which also have hidden assets। He adds that all of the rails are pro-shareholder.
Published by SeekingAlpha

Labels: CAG, CLX, CSX, Hot Stocks, Jim Cramer, NSC, UNP, VG, VZ

Heinz (NYSE: HNZ - News), Procter & Gamble (NYSE: PG - News), Bristol Myers (NYSE: BMY - News), Clorox (NYSE: CLX - News), Colgate (NYSE: CL - News)
Cramer says that defensive stocks like HNZ, PG, BMY, CLX, and CL "make sense here" because you can be "short-term bearish within a long-term bullish environment." When Gregg Greenberg commented on risks of the yen carry trade, Cramer responded the yen carry trade has been going on for ages, there are times when it uwinds; "This is all business as usual within the context that it's very easy to scare people," Cramer said. "This is noise." He went on to say he can't find anything positive about tech, and noted commodities and gold are going down. Cramer predicts a disaster and a crisis before the Fed cut, and investing in soft goods and diversifiying are the only ways to weather the storm; "Nothing else is going to work."

Labels: BMY, CL, CLX, HNZ, Jim Cramer, PG, Wall Street Confidential

Gone Fishing: Procter & Gamble (NYSE: PG - News), Colgate (NYSE: CL - News), Clorox (NYSE: CLX - News), General Mills (NYSE: GIS - News), Heinz (HZ), Altria (NYSE: MO - News), Pfizer (NYSE: PFE - News), Eli Lilly (NYSE: LLY - News), Celgene (NasdaqGS: CELG), Gilead (NasdaqGS: GILD)
Following Tuesday's massive selloff, Cramer says its time to go fishing for stocks that have bottomed, a technique that is really "more of a science than an art." First, investors should cast their lines "gingerly and steadily," have a strategy and patience, since not all sectors bottom at the same time. For example, food and drug stocks bottomed "because the slowdown camp is now in charge on Wall Street." Although it is reasonable to question the wisdom of jumping behind defensive stocks, Cramer recommends following where the big money leads. In addition, he thinks perceptions of market sluggishness might influence the Fed to cut interest rates. Although he thinks PG is too high, Cramer suggests buying CL, CLX, GIS and HZ, and especially likes MO because it has a "sweet 4% yield" and is splitting up. Cramer rejects LLY and PFE because he sees them as risky and doesn't predict much upside; he would instead pick up biotechs CELG and GILD.
Falling Financials : Goldman Sachs (NYSE: GS - News), Capital One Financial (NYSE: COF - News), Bank of America (NYSE: BAC - News), T. Rowe Price (NasdaqGS: TROW), Citigroup (NYSE: C - News)
Cramer sees a bottom in financials in two weeks, noting "subprime lenders are busted," which will cause the Fed to lower rates. He has confidence in banks and brokers and comments when the "big money decides to join the smart money, the financials will fly." He comments that GS and COF perform "fabulously" when short-interest rates go below long-interest rates. He also recommended BAC, TROW and even Citigroup.
Published By SeekingAlpha

Labels: BAC, C, CELG, CL, CLX, COF, GILD, GIS, GS, Jim Cramer, LLY, Mad Money, MO, pfe, PG

Bullish calls:
Colgate-Palmolive (NYSE: CL - News): ' You know, that is a truly great American company. It was a fabulous number ... CL is on a tear, plus their big in Latin America. They have a big business overseas ... Holy cow. It's time to back up the truck. Cleanest quarter in the whole group, with the exception perhaps with CLX.'Clorox (NYSE: CLX - News)NYSE Group (NYSE: NYX - News): 'Goldman Sachs reiterated today, saying they like the quarter. I think the merger with EuroNext is going to produce gigantic numbers. A lot of people are impatient. It's been a great recommendation since the mid-60s and I am sticking by it ... This is a big stock for 2007.'Respironics (NasdaqGS: RESP): 'I believe very strongly that RESP's sleep apnea franchise is a strong one. It's down 2 bucks from its high. And I say, bring me some RESP - buy, buy, buy! Bring it to me!'Wyeth (NYSE: WYE - News): ' ... that's become one of my favorite ones.'Comcast (NasdaqGS: CMCSA): 'I have heard many different worries about CMCSA ... I am banking with Brian Roberts, the CEO. I think that they're spending more money to get a lot more revenues... I feel that they are doing all the right things. There are very few capitalization companies that have growth - that they can even put money behind. CMCSA is one of them ... That stock should be bought, and it should be bought nine ways to Sunday. Buy, buy, buy!'CA (NYSE: CA - News): 'They just reported an upside surprise.'World Wrestling Entertainment (NYSE: WWE - News): 'Here's the thing: WWE has done absolutely nothing since I recommended it, but you got a 6% yield. And you know what? ... I am sticking by WWE, because of international business.'Washington Mutual (NYSE: WM - News): 'Oh man, too cheap with a good dividend.'Cisco (NasdaqGS: CSCO)MRV Communications (NasdaqGM: MRVC)
Bearish calls:
Sirius Satellite Radio (NasdaqGS: SIRI): 'I've given up. I recommended this stock on the basis of takeover, which you should never do. I violated all my own rules ... the fundamentals don't support it.'Rackable Systems (NasdaqGS: RACK): 'I believe that, if you hold this stock until August/September, you'll get some lift, but I cannot tell you anything good about RACK. That may have been the worst quarter in 2007. don't buy, don't buy. And, with any lift, sell, sell, sell!'Par Pharmaceutical (NYSE: PRX - News): 'Now, you know, one of my problems is I have not liked the generic stocks ... The companies that make generic drugs are commodity companies. They have nothing proprietary... Sell, sell, sell! I don't want that stock in your portfolio.'Informatica (NasdaqGS: INFA): Ciena (NasdaqGS: CIEN): 'No. I'd rather see you in MRVC. Use a limit please.'Tellabs (NasdaqGS: TLAB): 'Oh c'mon, CSCO's killing them. You don't need that TLAB.'
Published by SeekingAlpha

Labels: CA, CIEN, CL, CLX, CSCO, Hot Stocks, INFA, Jim Cramer, Lightning Round, Mad Money, NYX

AGL Resources (NYSE:ATG - News) reported fourth-quarter earnings of $47 million, or 60 cents a share, and said it expects a profit of $2.75 to $2.85 a share for fiscal 2007. The Atlanta-based energy services provider also said its board has approved an 11% hike in its annual dividend rate to $1.64 a share.
Alliant Techsystems (NYSE:ATK - News) reported third-quarter earnings rose 8.8% on 17% higher revenue. Earnings reached $51.2 million, or $1.53 a share, from $47.1 million, or $1.26, in the year-earlier period. Revenue rose to $900.3 million from $770 million. A survey of analysts by Thomson Financial produced consensus estimates of $1.32 a share on revenue of $844 million. ATK lifted its estimate of earnings for fiscal 2007 to $5.10 to $5.15 a share, from its previous estimate of $4.95 to $5.05. And it now estimates sales at $3.5 billion, up from an earlier estimate of more than $3.45 billion.
American Standard Cos. Inc. (NYSE:ASD - News) reported fourth-quarter earnings of $114.3 million, or 56 cents a share, up from a year-ago profit of $64.4 million, or 30 cents a share. On an adjusted basis, excluding certain items, the company earned $104.5 million, or 51 cents a share, in the latest quarter. Sales at the Piscataway, N.J., maker of air conditioning systems as well as bath and kitchen products rose to $2.7 billion in the three months ended Dec. 31 from $2.55 billion in the same period a year earlier. The average estimate of analysts polled by Thomson Financial was for a profit of 51 cents a share in the December period. Looking ahead, the company forecast adjusted earnings of $3.15 to $3.25 a share for fiscal 2007 on sales growth of about 8%. For the first quarter, it sees adjusted earnings of 48 to 52 cents a share with sales rising about 6%. Wall Street's current consensus estimate is for a profit of $3.08 a share for the year and 48 cents a share in the March period. The company also announced a restructuring plan calling for the separation of its three businesses.
Archer Daniels Midland (NYSE:ADM - News) said higher prices for the biofuel offset rising corn costs in its fiscal second quarter. Overall corn processing operating profits rose $99 million for the quarter to $335 million. "Increased starch, sweetener and ethanol selling prices contributed to the earnings improvement and were partially offset by increasing net corn costs," the company said. The Decatur, Ill.-based company also said fiscal second-quarter earnings rose to $441.3 million, or 67 cents a share, from $367.7 million, or 56 cents a share, a year earlier. Revenue for the quarter ending December increased 18% to $10.98 billion from last year's $9.3 billion. Analysts surveyed by Thomson Financial had been expecting earnings of 60 cents a share and revenue of $9.52 billion, on average.
Armor Holdings Inc. (NYSE:AH - News) said fourth-quarter net income rose to $37.8 million, or $1.02 a share, from $37.6 million, of $1.04 a share, during the same period in the prior year.
AstraZeneca (NYSE:AZN - News) announced plans to cut 3,000 jobs over the next three years. It will take $500 million in charges, of which $300 million will be in cash, the drugmaker said. The company also reported that its fourth-quarter profit before tax jumped 25% to $2.1 billion, after sales climbed 14% to $7.15 billion. The Anglo-Swedish pharmaceutical said sales of its top five growth products -- Nexium, Seroquel, Crestor, Arimidex and Symbicort -- rose 23% to $3.7 billion. It hikes its dividend 32% for the year to $1.72 a share and plans to buy back $4 billion in shares during 2007. AstraZeneca said 2007 earnings are seen in the range of $3.80 to $4.05 a share, excluding the impact of U.S. sales of Toprol XL and any productivity initiatives.
Brink's Co. (NYSE:BCO - News) reported fourth-quarter net income more than doubled due to earnings from discontinued operations. Fourth-quarter net reached $126.6 million, or $2.71 a share, from $47.7 million, or 83 cents, in the year-earlier period. Shares outstanding fell 19% to 46.7 million. Earnings from continuing operations were 71 cents a share against 11 cents as profit and revenue rose in both of Brink's operating units. Revenue rose 14% to $755.9 million from $663.1 million. A survey of analysts by Thomson Financial produced consensus estimates of 62 cents of profit on $723 million of revenue.
Carbo Ceramics (NYSE:CRR - News) reported fourth-quarter earnings of $15 million, or 61 cents a share, up from a year-ago profit of $10.4 million, or 43 cents a share. Revenue rose in the latest three months to $87 million from $63.6 million a year earlier.
Celgene (NasdaqGS:CELG - News) fourth-quarter earnings rose to $22.9 million, or 6 cents a share, from $3.93 million, or a cent a share, a year earlier. The company said adjusted earnings rose to $74.5 million, or 18 cents a share, from $10.2 million, or 3 cents a share. Analysts polled by Thomson Financial expected, on average, fourth-quarter earnings of 18 cents a share on revenue of $268.4 million. The Summit, N.J., pharmaceutical company said total revenue rose 84% to $275 million from $149.3 million in the year-ago period, helped by sales of Revlimid and Thalomid. Product sales rose to $251.9 million from $128.7 million.
Children's Place Retail Stores (NasdaqGS:PLCE - News) said it earned $38 million in the third quarter as sales rose 25% to $550.4 million, according to preliminary data. The figures may be revised as the company continues to work on a restatement of past results to correct the accounting for stock option grants. Same-store sales rose 14% in the quarter, the Secaucus, N.J. retailer said in a statement. Thomson Financial was looking for sales of $548.5 million. The company said it now expects net income of $45 to $48 million in the fourth quarter. For January, same-store sales are expected to decline at a mid-single digit rate at its Children's Place stores and rise at a pace in the mid-twenties at Disney stores. For fiscal 2007, the company is expecting earnings of $3.55 to $3.65 a share.
Christopher & Banks Corp. (NYSE:CBK - News) said it expects earnings of 7 to 8 cents a share for the fourth quarter, below Wall Street's consensus estimate for a profit of 14 cents a share. The Minneapolis-based women's clothing retailer said aggressive markdowns in the quarter led to lower average unit retails.
Clorox (NYSE:CLX - News) said its second-quarter earnings rose 16%, boosted by record sales of its Fresh Step cat litter, higher sales of Kingsford grilling products and increased shipments of home-care products in Mexico and Argentina.
Concur Technologies Inc. (NasdaqGM:CNQR - News) reported first-quarter net earnings of $993,000, or 2 cents a share, up 53% from $648,000, or 2 cents a share, during the year-ago period. There were 40.2 million shares outstanding during the quarter compared with 36.5 million a year ago.
Cutera (NasdaqGS:CUTR - News) shares rose after the Brisbane, Calif.-based company reported fourth-quarter net earnings of $7.12 million, or 50 cents a share, up from $5.81 million, or 41 cents a share, in the year-ago period. Excluding items, earnings came in at 55 cents a share. Revenue rose to $30.5 million from $24 million. Analysts polled by Thomson Financial were expecting earnings of 41 cents a share on revenue of $30.2 million. The company expects first-quarter earning of 21 cents a share, or 28 cents a share excluding items, on revenue of $26 million, and 2007 earnings of $1.30 a share, or $1.57 a share excluding items, on revenue of $126 million.
Dell (NasdaqGS:DELL - News) named company founder Michael Dell chief executive effective immediately, to replace Kevin Rollins. The Round Rock, Texas, computer company said Dell will retain his duties as chairman.
Eli Lilly (NYSE:LLY - News) was upgraded to overweight from neutral at Prudential Equity, which cited expectations for earnings growth of around 10% over the next four years as well as an attractive current valuation. "Due to low generic exposure and what we believe is an increasingly stable base business, we see Eli Lilly growing earnings at above average rates for the next several years," Prudential said.
Elizabeth Arden (NasdaqGS:RDEN - News) posted a fiscal second-quarter profit of $26.2 million, or 92 cents a share, as sales rose 18.8% to $410.8 million. Looking ahead, the New York-based beauty products provider lifted the lower end of its outlook for fiscal 2007 earnings to $1.15 to $1.20 a share from the prior projection of $1.10 to $1.20 a share.
Gilead Sciences Inc. (NasdaqGS:GILD - News) swung to a fourth-quarter loss of $1.67 billion, or $3.62 a share. In the same period the year before, the company posted net earnings of $281.6 million, or 59 cents a share.
Green Mountain Coffee (NasdaqGS:GMCR - News) shares jumped after the company reported first-quarter earnings of $2.4 million, or 30 cents a share, down from a year-ago profit of $3 million, or 38 cents a share. On a non-GAAP basis, the Waterbury, Vt.-based coffee provider earned $3.7 million, or 46 cents a share, in the latest quarter. Looking ahead, Green Mountain sees non-GAAP earnings of $2.11 to $2.17 a share in fiscal 2007.
Helmerich & Payne (NYSE:HP - News) reported first-quarter earnings of $110.8 million, or $1.06 a share, on operating revenue of $386.4 million. In the same period a year earlier, the company earned $50.8 million, or 48 cents a share, on revenue of $255.4 million. The latest results include a gain of 15 cents a share from the sale of portfolio securities, while last year's report reflects 2 cents a share in similar gains.
Published By MarketWatch

Labels: ADM, AH, ASD, ATG. ATK, AZN, BCO, CBK, CELG, CLX, CNQR, CRR, CUTR, DELL, GILD, GMCR, HP, LLY, PLCE, RDEN